wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26738598-6310EF77-F151-432E-8D2B-2FBC9EEA0DA3
Q26738598-6310EF77-F151-432E-8D2B-2FBC9EEA0DA3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738598-6310EF77-F151-432E-8D2B-2FBC9EEA0DA3
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
P2860
Q26738598-6310EF77-F151-432E-8D2B-2FBC9EEA0DA3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738598-6310EF77-F151-432E-8D2B-2FBC9EEA0DA3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6e7f35ddff3606df2dc4077526fb199bc18f51bb
P2860
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.